CD137 ACTIVATION AUGMENTS THE EFFICACY OF EGFR-TARGETED THERAPY

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2014年 / 4卷 / 07期
关键词：
D O I：
10.1158/2159-8290.CD-RW2014-120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Major finding: Treatment with anti-CD137 mAb improves cetuximab efficacy by enhancing immune responses. Mechanism: Cetuximab induces CD137 on NK cells, and CD137 targeting stimulates ADCC and adaptive immunity. Impact: Dual antibody therapy may be beneficial in EGFR-positive cancers, including KRAS-mutant tumors. © 2014 American Association for Cancer Research.
引用
收藏
页码：758 / 758
页数：1
相关论文
共 50 条
  • [21] The role of pathologist in cancer patients selection for EGFR-targeted therapy
    Olszewski, Wojciech P.
    Olszewski, Wlodzimierz T.
    ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (05): : 228 - 235
  • [22] CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma
    Preethi Bala Balakrishnan
    Debbie K. Ledezma
    Juliana Cano-Mejia
    Jaclyn Andricovich
    Erica Palmer
    Vishal A. Patel
    Patricia S. Latham
    Eric S. Yvon
    Alejandro Villagra
    Rohan Fernandes
    Elizabeth E. Sweeney
    Nano Research, 2022, 15 : 2300 - 2314
  • [23] Resistance to EGFR-targeted therapy by Ets-1 inactivation
    Tetsu, Osamu
    Eisele, David W.
    McCormick, Frank
    CELL CYCLE, 2015, 14 (20) : 3211 - 3212
  • [24] Activation of the CD137 Pathway in T cells by a CD137 x 5T4 bispecific ADAPTIR Molecule Requires Co-engagement of CD137 and 5T4
    Blahnik-Fagan, Gabriele R.
    Bader, Robert
    Bannink, Jeannette
    Mitchell, Danielle
    Misher, Lynda
    McMahan, Cathy
    Bienvenue, David
    Fritzell, Sara
    Sall, Anna
    von Schantz, Laura
    Ellmark, Peter
    Nelson, Michelle
    Hernandez-Hoyos, Gabriela
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [25] Can the "Right" EGFR-Specific mAb Dramatically Improve EGFR-Targeted Therapy?
    Sabbatino, Francesco
    Ferrone, Soldano
    CLINICAL CANCER RESEARCH, 2013, 19 (05) : 958 - 960
  • [26] Expression of CD137 on Hodgkin and Reed-Sternberg Cells Inhibits T-cell Activation by Eliminating CD137 Ligand Expression
    Ho, Weng Tong
    Pang, Wan Lu
    Chong, Siew Meng
    Castella, Antonio
    Al-Salam, Suhail
    Tan, Teng Ee
    Moh, Mei Chung
    Koh, Liang Kai
    Gan, Shu Uin
    Cheng, Cheong Kin
    Schwarz, Herbert
    CANCER RESEARCH, 2013, 73 (02) : 652 - 661
  • [27] Activation of CD137 signaling accelerates vascular calcification in vivo and vitro
    Chen, Yao
    Bangash, Abdul Basit
    Song, Juan
    Zhong, Wei
    Wang, Cuiping
    Shao, Chen
    Wang, Zhongqun
    Yan, Jinchuan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 230 : 198 - 203
  • [28] Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy
    Chuang, Jody C.
    Shrager, Joseph B.
    Wakelee, Heather A.
    Neal, Joel W.
    CLINICAL THERAPEUTICS, 2016, 38 (07) : 1567 - 1576
  • [29] CD137 humanized mice for preclinical efficacy evaluation of therapeutic antibodies
    Jiang, Yunlong
    Gu, Tingting
    Yu, Weiwei
    Sun, Hongyan
    Zhang, Mingkun
    Liang, Juan
    Li, Shuai
    Ju, Cunxiang
    Zhao, Jing
    Gao, Xiang
    Moore, Mark W.
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Activation of CD137 signaling accelerates vascular calcification in vivo and vitro
    Bo, Li
    Chen, Yao
    Song, Juan
    Wang, Zhongqun
    Zhong, Wei
    Yan, Jinchuan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C11 - C11
12345